The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Ahsan, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00549-1 · Cited by 570 · cited 1×
“One of the major problems concerning the pulmonary administration of particulate systems is the rapid capture by the alveolar macrophages [3,22], a process known to be affected by several factors such as particle size, surface properties, composition and local concentration [23–25].”
Background
Cited by
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Formulation strategy and use of excipients in pulmonary drug delivery
Pilcer, G., & Amighi, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.017 · Cited by 791
Ahmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Chitosan-based delivery systems for protein therapeutics and antigens
Amidi, M., Mastrobattista, E., Jiskoot, W., & Hennink, W. E. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.009 · Cited by 620
Emerging micro- and nanotechnology based synthetic approaches for insulin delivery
Mo, R., Jiang, T., Di, J., Tai, W., & Gu, Z. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60436e · Cited by 386
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., & Alonso, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.026 · Cited by 354
Self-citationNanoparticle formulations in pulmonary drug delivery
Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302
Chitosan Amphiphilic Derivatives. Chemistry and Applications
Aranaz, I., Harris, R., & Heras, A. (2010) · Current Organic Chemistry · doi:10.2174/138527210790231919 · Cited by 294
Valorisation of natural extracts from marine source focused on marine by-products: A review
Ferraro, V., Cruz, I. B., Jorge, R. F., Malcata, F. X., Pintado, M. E., & Castro, P. M. L. (2010) · Food Research International · doi:10.1016/j.foodres.2010.07.034 · Cited by 274
Lipid-based nanocarriers for oral peptide delivery
Niu, Z., Conejos-Sánchez, I., Griffin, B. T., O’Driscoll, C. M., & Alonso, M. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.001 · Cited by 265
Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals
Emami, F., Vatanara, A., Park, E. J., & Na, D. H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030131 · Cited by 254
Bonferoni, M. C., Riva, F., Invernizzi, A., Dellera, E., Sandri, G., Rossi, S., Marrubini, G., Bruni, G., Vigani, B., Caramella, C., et al. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.11.008 · Cited by 72
Metadata
- Authors
- Grenha, A., Remuñán-López, C., Carvalho, E. L. S., & Seijo, B.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 69
- Issue
- 1
- Pages
- 83-93
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W1983414270
- Cited by
- 166
- References
- 2
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.